drugset / Trial / NCT02253901

Pharmacokinetic Interaction Between TRUVADA™ and BILR 355 BS Plus Ritonavir in Healthy Volunteers

NCT02253901

Phase 1 Completed 33 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

Study to determine the pharmacokinetic effect of BILR 355 + ritonavir® on TRUVADA and TRUVADA on BILR 355

Timeline

Start
2005-03
Primary completion
2005-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BILR 355 BS Unknown
Subject Ritonavir Other / unclassified
Subject Tenofovir Small molecule

Indications

No indication recorded.